Chief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable online platform that aims to make AI accessible to all drug discovery res
AstraZeneca has become the latest big pharma to jump on the artificial intelligence R&D bandwagon, penning a deal with the UK’s BenevolentAI to find new kidney and lung drugs.<
The UK government has handed out a further tranche of cash to digital health projects exploring artificial intelligence, machine learning, and hand-held devices.
Eleven years is a long time to be writing about ‘digital pharma’, and I do indeed remember when it was all My First Twitter Account and iPhone Apps as far as the eye could see.